Quatorze façons de cibler le lymphocyte B dans le traitement du lupus érythémateux systémique

This publication has 64 references indexed in Scilit:

• Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
  European Journal of Cancer, 2024
• French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases
  La Revue de Médecine Interne, 2024
• Gestion des toxicités des immunothérapies du cancer : challenges et « rechallenges » pour les (jeunes) internistes
  La Revue de Médecine Interne, 2023
• Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence
  Kidney International Reports, 2023
• Plasmablast‐like Phenotype Among Antigen‐Experienced CXCR5–CD19^low B Cells in Systemic Lupus Erythematosus
  Arthritis & Rheumatology, 2022
• A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases
  Arthritis & Rheumatology, 2021
• Kidney Tertiary Lymphoid Structures in Lupus Nephritis Develop into Large Interconnected Networks and Resemble Lymph Nodes in Gene Signature
  The American Journal of Pathology, 2020
• Treize raisons pour ne pas cibler le lymphocyte B dans le traitement du lupus érythémateux systémique
  La Revue de Médecine Interne, 2019
• Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls
  Journal of Autoimmunity, 2017
• Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
  Arthritis & Rheumatology, 2017